Ryukichi Matsui
Shimane University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ryukichi Matsui.
Frontiers in Neurology | 2016
Ryukichi Matsui; Tomonori Nakagawa; Hiroyuki Takayoshi; Keiichi Onoda; Hiroaki Oguro; Atsushi Nagai; Shuhei Yamaguchi
Atherosclerotic stenosis of major intracranial arteries is a leading cause of ischemic stroke in Asia. However, the long-term prognosis of asymptomatic intracranial atherosclerotic stenosis (ICAS) in healthy volunteers has not been fully examined. Here, we conducted a longitudinal study to examine the prognosis of healthy volunteers with asymptomatic ICAS and to determine the risk factors for ICAS, including asymptomatic brain parenchymal lesions. We studied 2,807 healthy Japanese volunteers with no history of stroke (mean age, 62.0 years). They were followed for a mean interval of 64.5 months. The degree of ICAS and the presence of asymptomatic brain lesions were assessed by using magnetic resonance imaging. Asymptomatic ICAS was detected in 166 volunteers (5.9%) at the initial examination. Moderate and mild stenoses were observed in 1.5 and 4.4% of patients, respectively. Significant risk factors for ICAS were older age and a history of hypertension and/or dyslipidemia. During follow-up, ischemic stroke developed in 32 volunteers. Seven strokes occurred in the ICAS group, whose stroke incidence rate was higher than that in the non-ICAS group (0.78 vs. 0.18% per year). According to a Cox regression analysis, asymptomatic ICAS was an independent risk factor for future ischemic stroke after adjustment for age. Furthermore, after asymptomatic brain lesions were taken into account, ICAS was still a significant risk factor for stroke onset. In conclusion, even mild to moderate asymptomatic ICAS was a significant risk factor for future stroke, independent of asymptomatic brain lesions, in a healthy Japanese population. Mild to moderate ICAS might be a therapeutic target for stroke prevention.
Kampo Medicine | 2007
Ryukichi Matsui; Shotai Kobayashi
Kampo Medicine | 2001
Ryukichi Matsui; Koichi Shimode; Naoto Kohno; Genya Toyota; Kaoru Imaoka; Shotai Kobayashi; Katsutoshi Terasawa
Stroke | 2012
Ryukichi Matsui; Hiroaki Oguro; Nagai Atsushi; Hirokazu Bokura; Keiichi Onoda; Shoutai Kobayashi; Shuhei Yamaguchi
Kampo Medicine | 2012
Ryukichi Matsui; Takuya Yamaguchi; Shotai Kobayashi; Atsushi Nagai; Shuhei Yamaguchi
Kampo Medicine | 2012
Ryukichi Matsui; Takuya Yamaguchi; Shotai Kobayashi; Atsushi Nagai; Shuhei Yamaguchi
Kampo Medicine | 2011
Ryukichi Matsui; Shotai Kobayashi; Takuya Yamaguchi; Atsushi Nagai; Syuhei Yamaguchi
Archive | 2010
Kazuo Takahashi; Ryukichi Matsui; Shingo Yamagata; Shotai Kobayashi; Diffusion-Weighted Mri
Japanese journal of geriatrics | 2010
Shingo Mitaki; Satoshi Abe; Akira Shirasawa; Ryukichi Matsui; Genya Toyoda; Hirokazu Bokura; Shuhei Yamaguchi
Nihon Toyo Igaku Zasshi (Kampo Medicine) | 2009
Ryukichi Matsui; Shotai Kobayashi